Theravance Biopharma (TBPH) Technical (Analysis) Reports Theravance Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Theravance Biopharma (TBPH)
Technical Analysis Report for NASDAQ stock TBPH Theravance Biopharma. Dated: 10 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock TBPH Theravance Biopharma then click here. or read Experts views on Theravance Biopharma or Forecast & share price targets of Theravance Biopharma
Theravance Biopharma Opened at 17.00 and Closed at: 16.94, which is -0.3% of previous session's close. It moved within a range of 16.91 and 17.02
The session was a Bearish session with an average volume of 670862, which is 58.61% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Golden cross was found 1 days back on long term averages
Support for tomorrow is 16.87 and resistance for tomorrow is 16.98
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 16.89, 16.85 resistance for tomorrow's hourly charts is 17, 17.07
10 Day SMA for Theravance Biopharma (TBPH) is 17.05 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Theravance Biopharma (TBPH) is 16.91 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Theravance Biopharma (TBPH) is 16.63 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 16.39 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Theravance Biopharma is 16.9 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Theravance Biopharma is at 16.91 and 200 DMA is at 16.9, while 50 DMA and 100 DMA are at 16.63 and 16.39 respectively
Theravance Biopharma (TBPH) moving average of 20 SMA is at 16.91 and 20 EMA is at 16.88
| Date | Closing Price | 20 SMA | 20 EMA |
| 10 Fri Jul | 16.94 | 16.91 | 16.88 |
| 09 Thu Jul | 16.99 | 16.88 | 16.87 |
| 08 Wed Jul | 17.00 | 16.85 | 16.86 |
| 07 Tue Jul | 17.01 | 16.82 | 16.85 |
| 06 Mon Jul | 17.00 | 16.78 | 16.83 |
| 02 Thu Jul | 16.93 | 16.75 | 16.81 |
Theravance Biopharma (TBPH) moving average of 50 SMA is at 16.63 and 50 EMA is at 16.69
| Date | Closing Price | 50 SMA | 50 EMA |
| 10 Fri Jul | 16.94 | 16.63 | 16.69 |
| 09 Thu Jul | 16.99 | 16.63 | 16.68 |
| 08 Wed Jul | 17.00 | 16.62 | 16.67 |
| 07 Tue Jul | 17.01 | 16.62 | 16.66 |
| 06 Mon Jul | 17.00 | 16.61 | 16.65 |
| 02 Thu Jul | 16.93 | 16.59 | 16.64 |
Theravance Biopharma (TBPH) moving average of 100 SMA is at 16.39 and 100 EMA is at 16.71
| Date | Closing Price | 100 SMA | 100 EMA |
| 10 Fri Jul | 16.94 | 16.39 | 16.71 |
| 09 Thu Jul | 16.99 | 16.42 | 16.71 |
| 08 Wed Jul | 17.00 | 16.44 | 16.7 |
| 07 Tue Jul | 17.01 | 16.47 | 16.69 |
| 06 Mon Jul | 17.00 | 16.49 | 16.68 |
| 02 Thu Jul | 16.93 | 16.52 | 16.67 |
Theravance Biopharma (TBPH) moving average of 200 SMA is at 16.9 and 200 EMA is at 16.02
| Date | Closing Price | 200 SMA | 200 EMA |
| 10 Fri Jul | 16.94 | 16.9 | 16.02 |
| 09 Thu Jul | 16.99 | 16.88 | 16.01 |
| 08 Wed Jul | 17.00 | 16.87 | 16 |
| 07 Tue Jul | 17.01 | 16.85 | 15.99 |
| 06 Mon Jul | 17.00 | 16.84 | 15.98 |
| 02 Thu Jul | 16.93 | 16.82 | 15.97 |
Theravance Biopharma has performed better than Utah Medical in short term. Holding Theravance Biopharma could be a better choice for now!
Tiziana Life has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Tiziana Life, about 4.35% more returns!
Bio Techne has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Bio Techne, about 29.24% more returns!
Summit Therapeutics has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Summit Therapeutics, about 14.12% more returns!
Theravance Biopharma has performed better than Scynexis Inc in short term. Holding Theravance Biopharma could be a better choice for now!
Regenxbio Inc has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Regenxbio Inc, about 119.4% more returns!
Theravance Biopharma has performed better than Pulse Biosciences in short term. Holding Theravance Biopharma could be a better choice for now!
Ovid Therapeutics has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Ovid Therapeutics, about 11.3% more returns!
Myriad Genetics has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Myriad Genetics, about 23.4% more returns!
Moderna Inc has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Moderna Inc, about 34.8% more returns!
Theravance Biopharma has performed better than Atossa Genetics in short term. Holding Theravance Biopharma could be a better choice for now!
Celldex Therapeutics has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 27.81% more returns!
Cellectar Biosciences has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Cellectar Biosciences, about 22.6% more returns!
Theravance Biopharma has performed better than Dexcom Inc in short term. Holding Theravance Biopharma could be a better choice for now!
Ensign Group has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Ensign Group, about 11.84% more returns!
Henry Schein has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Henry Schein, about 2.44% more returns!
Icon Plc has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Icon Plc, about 9.3% more returns!
Theravance Biopharma has performed better than Ionis Pharmaceuticals in short term. Holding Theravance Biopharma could be a better choice for now!
Theravance Biopharma Technical analysis of indicators
Price action analysis of Theravance Biopharma (TBPH) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Theravance Biopharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Theravance Biopharma in short term but the sell signal is initial and weak.
Theravance Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Theravance Biopharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Theravance Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 17.07 and Theravance Biopharma TBPH stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma TBPH stock. Volume based technical analysis of Theravance Biopharma TBPH stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock TBPH Theravance Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And TBPH Experts View which covers a lot of information including buying and selling signals
TBPH future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Theravance Biopharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Theravance Biopharma (TBPH) Technical (Analysis) Reports Theravance Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


